Avantor Inc.
AVTR | NYSE
$15.52
-$0.34 (-2.14%)
At close: Sep 18, 2026, 4:00 PM ET
$15.51
-$0.01 (-0.06%)
After-hours:
Sep 18, 2026, 7:30 PM ET
Company Profile
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
Key Executives
| Name | Position |
|---|---|
| Emmanuel Ligner | President, Chief Executive Officer & Director |
| Mary Blenn | Executive Vice President & Chief Operating Officer |
| Michael Wondrasch | Executive Vice President & Chief Information Officer |
| Benoit Gourdier | Executive Vice President of Bioscience Production |
| Brittany Hankamer | Executive Vice President & Chief Human Resources Officer |
| Chris Fidyk | Vice President of Investor Relations |
| Christophe Couturier | Executive Vice President of AMEA |
| Claudius O. Sokenu | Executive Vice President, Corporate Secretary and Chief Legal & Compliance Officer |
| Corey D. Walker | President of Laboratory Solutions |
| Steven W. Eck | Senior VP, Interim CFO, Corporate Controller & Chief Accounting Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 27, 2026 | 8-K/A | [Amend] Current Report |
| Aug 20, 2026 | 4 | Filing |
| Aug 18, 2026 | 4 | Filing |
| Aug 04, 2026 | 4 | Filing |
| Jul 29, 2026 | 10-Q | Quarterly Report |
| Jul 29, 2026 | 8-K | Current Report |
| Jul 27, 2026 | 4 | Filing |
| Jul 17, 2026 | 8-K | Current Report |
| Jun 22, 2026 | 4 | Filing |
| May 29, 2026 | SD | Filing |
Avantor Inc.
| Country | United States |
| IPO Date | May 16, 2019 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 13,500 |
| CEO | Emmanuel Ligner |
Contact Details
Radnor Corporate Center Radnor,
Pennsylvania 19087 United States
Stock Details
| Ticker Symbol | AVTR |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001722482 |
| CUSIP Number | 05352A100 |
| ISIN Number | US05352A1007 |
| SIC Code | 3826 |
Recent News
- 6 hours ago / prnewswire.comAvantor appoints new Chief Financial Officer
- 3 days ago / zacks.comAvantor Broadens RIM Single-Use Bioprocessing Reach in APAC
- 5 days ago / zacks.comHere's Why You Should Add Avantor Stock to Your Portfolio for Now
- 17 days ago / zacks.comIs Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?
- 24 days ago / zacks.comWhy Is Avantor (AVTR) Up 5.4% Since Last Earnings Report?
- 27 days ago / zacks.comIs Avantor a Buy as Revival Progress Faces Persistent Margin Pressure?
- 1 month ago / zacks.comIs Avantor (AVTR) Outperforming Other Medical Stocks This Year?
- 2 months ago / zacks.comAre Medical Stocks Lagging Avantor (AVTR) This Year?
- 2 months ago / zacks.comAvantor, Inc. (AVTR) Just Flashed Golden Cross Signal: Do You Buy?
- 2 months ago / zacks.comAvantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised
Add to Watchlist
Select watchlists to add or remove AVTR